News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TransTech Pharma, Inc. And Boehringer Ingelheim Corporation Initiate $54 Million Drug Discovery Collaboration


12/21/2005 10:59:10 AM

HIGH POINT, N.C.--(BUSINESS WIRE)--Dec. 21, 2005--TransTech Pharma, Inc. today announced a worldwide research and license collaboration with Boehringer Ingelheim GmbH using TransTech's proprietary TTP Translational Technology(R). The aim of the collaboration is to discover and develop novel small molecules as therapeutics against an undisclosed biological target of interest to both companies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES